Optimizing Cell Potency, Safety & Viability with Robust
Analytical Packages
Enhance Product Characterization, Method Validation & Release Testing with Novel Immunophenotype, Molecular & Cell-Based Assays to Drive Clinical Development & Gain Regulatory Approval
Remaining the industry’s leading forum for cell therapy analytical professionals, the 7th Cell Therapy Analytical Development Summit will delve into cutting-edge technologies and proven strategies to aid you in demonstrating product safety, functionality, and quality before heading to market.
Covering early- to late-stage assay development, focus your learning and address your specific analytical needs with our refined two-track format. No matter where you are in the product development cycle, gain hands-on expertise from designing predictive potency assays, through to validating and transferring methods for late-phase trials.
Featuring first-hand case studies and experiences from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the National Institute of Health, seize the opportunity to benchmark against peers, exchange solutions to persistent challenges, and strengthen your analytical toolkit, to excel in an increasingly competitive cell therapy landscape.
I look forward to engaging with my colleagues and identifying the common challenges we are all facing. Recognizing common approaches and sharing best practices is how the field of cell therapy succeeds together
Principal Quality Engineer, Avobis Bio, 2025 Speaker
View the Full Event Agenda – Your All-in-One Resource for the 2025 Meeting!
• 25+ industry-leading speakers from top pharma, biotech and academia
• 2 dedicated tracks of content, spanning each phase of cell therapy development
• An ASCP/ACP and CMLE-accredited workshop
• Real-world expertise from recent FDA leadership and regulatory bodies
The World-Class Speaker Faculty:
Who Will You Meet?
Proud to Partner With:
Lead Partner
Official Partners
Hear It from the Experts:
Multiple speakers used case studies as conversation starters which made discussions extremely productive and encouraged more people to share their own company's work
Cell Therapy & Viral Vector Analytical Development Scientist, Adicet Bio, 2024 Attendee
This meeting was very insightful and provided plenty of learning opportunities from those sharing similar issues, in particular potency and regulatory compliance
Principal Scientist, Arsenal Bio, 2024 Attendee
